(Total Views: 591)
Posted On: 08/17/2020 2:53:34 PM
Post# of 148899
We are the first drug to show a statistically significant improvement in this population. There is an unmet need.
Leronlimab meets every requirement for EUA. Whether the FDA awards is to be seen.
With respect to the phase 3 trial, it doesnt need to be large and if we are awarded an EUA, it will enroll very quickly.
Even without EUA, it will likely enroll faster than the phase 2 given the positive results.
Leronlimab meets every requirement for EUA. Whether the FDA awards is to be seen.
With respect to the phase 3 trial, it doesnt need to be large and if we are awarded an EUA, it will enroll very quickly.
Even without EUA, it will likely enroll faster than the phase 2 given the positive results.
(2)
(0)Scroll down for more posts ▼
